Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus

Published Date: 06 Sep 2024

Patient achieves remission with biologic agent currently used for myeloma

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Including Isatuximab with a Standard Backbone Enhances Multiple Myeloma Results.

2.

Early Sugar Exposure and Cancer Risk; Melanoma Vaccine Win; 'Antifreeze' for CAR-T

3.

Utilizing cerium/lanthanum-134 to improve cancer detection and treatment.

4.

Promising for Monitoring and Diagnosis of AD is the finger-prick test.

5.

Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot